The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy
Abstract
PURPOSE OF REVIEW: To provide an update on current management of retinoblastoma RECENT FINDINGS: The current major treatment strategies for retinoblastoma involve enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Enucleation is reserved for eyes with extensive retinoblastoma, in which there is no hope for useful vision. Newer implants following enucleation allow excellent cosmetic and motility outcome. Intravenous chemoreduction has been popular for nearly two decades and continues to provide favorable tumor control for most eyes classified as groups A, B, or C and some D eyes, using the International Classification of Retinoblastoma. Using chemoreduction, there has been an apparent reduction in the incidence of pinealoblastoma in children with germline mutation retinoblastoma. Intra-arterial chemotherapy involves single-agent injection into the ophthalmic artery under careful neurointerventional guidance. This recently popularized therapy can be useful for eyes that fail standard treatments or for some eyes as a primary treatment. Short-term results are favorable but longer follow-up is warranted. SUMMARY: Progress has been made in the past few years in the management of retinoblastoma with better enucleation implants, chemoreduction-prevention of pinealoblastoma and excellent tumor control, and we face the recently popularized modality of intra-arterial chemotherapy with caution and hope.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kivela, T. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.150292 · Cited by 721
Intraocular Retinoblastoma: the Case for a New Group Classification
LINNMURPHREE, A. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.11.003 · Cited by 683
Chemotherapy Plus Local Treatment in the Management of Intraocular Retinoblastoma
Murphree, A. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140548005 · Cited by 468
Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Gallie, B. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140521001 · Cited by 416
Chemoreduction in the Initial Management of Intraocular Retinoblastoma
Shields, C. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140530002 · Cited by 360
Self-citationThe technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma
Yamane, T., Kaneko, A., & Mohri, M. (2004) · International Journal of Clinical Oncology · doi:10.1007/s10147-004-0392-6 · Cited by 316
Choroidal invasion of retinoblastoma: metastatic potential and clinical risk factors.
Shields, C. L., Shields, J. A., Baez, K. A., Cater, J., & De Potter, P. V. (1993) · British Journal of Ophthalmology · doi:10.1136/bjo.77.9.544 · Cited by 220
Self-citationA phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma
Abramson, D. H., Frank, C. M., & Dunkel, I. J. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90406-2 · Cited by 200
Survival with retinoblastoma in the USA: 1975-2004
Broaddus, E., Topham, A., & Singh, A. D. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.143842 · Cited by 199
Shields, C. L. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.4.460 · Cited by 196
Self-citation
Cited by
Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review
Yousef, Y. A., Soliman, S. E., Astudillo, P. P. P., Durairaj, P., Dimaras, H., Chan, H. S. L., Héon, E., Gallie, B. L., & Shaikh, F. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0244 · Cited by 370
At-Risk Populations for Osteosarcoma: The Syndromes and Beyond
Calvert, G. T., Randall, R. L., Jones, K. B., Cannon-Albright, L., Lessnick, S., & Schiffman, J. D. (2012) · Sarcoma · doi:10.1155/2012/152382 · Cited by 90
Metadata
- Authors
- Shields, C. L., & Shields, J. A.
- Venue
- Current Opinion in Ophthalmology
- Published
- 2010-05
- Volume
- 21
- Issue
- 3
- Pages
- 203-212
- ISSN
- 1040-8738 (ISSN-L)
- OpenAlex
- W2074511633
- Cited by
- 280
- References
- 19
- FWCI
- 25.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. https://app.cochat.ai/papers/10.1097/icu.0b013e328338676a
- The paper
- Shields, C. L., & Shields, J. A. (2010). Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Current Opinion in Ophthalmology. https://doi.org/10.1097/icu.0b013e328338676a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.